Table 2.
PI-RADS score and cancer detection rates (n = 148).
| PI-RADS | Frequency | MRI-fusion biopsy | |
|---|---|---|---|
| All PCa | Sig PCa | ||
| 1/2∗ | 28 | 4 (14%) | 2 (7%) |
| 3 | 80 | 30 (38%) | 17 (21%) |
| 4 | 55 | 38 (69%) | 33 (60%) |
| 5 | 22 | 20 (91%) | 18 (82%) |
| Total | 185 | 92 | 70 |
PCa = prostate cancer, Sig = significant.
∗Due to clinical reasons these patients with PI-RADS 1/2 ROIs underwent targeted biopsy.